Exagen Aktie
WKN DE: A2PRXT / ISIN: US30068X1037
|
29.07.2025 14:08:56
|
Exagen Inc Q2 Loss Increases, Misses Estimates
(RTTNews) - Exagen Inc (XGN) announced Loss for its second quarter that increased from last year and missed the Street estimates.
The company's earnings totaled -$4.44 million, or -$0.21 per share. This compares with -$2.97 million, or -$0.16 per share, last year.
Analysts on average had expected the company to earn -$0.15 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 14.2% to $17.20 million from $15.06 million last year.
Exagen Inc earnings at a glance (GAAP) :
-Earnings: -$4.44 Mln. vs. -$2.97 Mln. last year. -EPS: -$0.21 vs. -$0.16 last year. -Revenue: $17.20 Mln vs. $15.06 Mln last year.
-Guidance: Full year revenue guidance: $65 Mln - $70 Mln
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Exagen Inc Registered Shsmehr Nachrichten
|
28.07.25 |
Ausblick: Exagen gewährt Anlegern Blick in die Bücher (finanzen.net) |
Analysen zu Exagen Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
| Exagen Inc Registered Shs | 10,10 | 1,51% |
|